<code id='5E86354787'></code><style id='5E86354787'></style>
    • <acronym id='5E86354787'></acronym>
      <center id='5E86354787'><center id='5E86354787'><tfoot id='5E86354787'></tfoot></center><abbr id='5E86354787'><dir id='5E86354787'><tfoot id='5E86354787'></tfoot><noframes id='5E86354787'>

    • <optgroup id='5E86354787'><strike id='5E86354787'><sup id='5E86354787'></sup></strike><code id='5E86354787'></code></optgroup>
        1. <b id='5E86354787'><label id='5E86354787'><select id='5E86354787'><dt id='5E86354787'><span id='5E86354787'></span></dt></select></label></b><u id='5E86354787'></u>
          <i id='5E86354787'><strike id='5E86354787'><tt id='5E86354787'><pre id='5E86354787'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:62775
          Darron Cummings/AP

          Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

          The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

          advertisement

          Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Failure, not just success, should guide future doctors
          Failure, not just success, should guide future doctors

          AdobeMatchDay,whichrolledaroundthisyearonMarch15,isarguablyoneofthemostimportantdaysinadoctor’slife.

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Air quality improving but still lags in Black, Hispanic communities

          High-risebuildingsindowntownLosAngelesseenonahazymorning.FREDERICJ.BROWN/AFPviaGettyImagesTheU.S.ism